CN105902690A - 一种应用于风湿性关节炎的中药香皂 - Google Patents
一种应用于风湿性关节炎的中药香皂 Download PDFInfo
- Publication number
- CN105902690A CN105902690A CN201610434434.1A CN201610434434A CN105902690A CN 105902690 A CN105902690 A CN 105902690A CN 201610434434 A CN201610434434 A CN 201610434434A CN 105902690 A CN105902690 A CN 105902690A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- chinese medicine
- traditional chinese
- rheumatic arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000344 soap Substances 0.000 title claims abstract description 38
- 201000003068 rheumatic fever Diseases 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 47
- 239000010495 camellia oil Substances 0.000 claims abstract description 22
- 241000005787 Cistanche Species 0.000 claims abstract description 21
- 229940094952 green tea extract Drugs 0.000 claims abstract description 19
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 239000002994 raw material Substances 0.000 claims description 20
- 240000000560 Citrus x paradisi Species 0.000 claims description 19
- 241001489978 Eupolyphaga Species 0.000 claims description 19
- 241000180649 Panax notoginseng Species 0.000 claims description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 19
- 241000131808 Scolopendra Species 0.000 claims description 19
- 241000522620 Scorpio Species 0.000 claims description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 19
- 239000009490 scorpio Substances 0.000 claims description 19
- 229940038481 bee pollen Drugs 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 241000533849 Gleditsia Species 0.000 claims description 5
- 241000241413 Propolis Species 0.000 claims description 5
- 229920000297 Rayon Polymers 0.000 claims description 5
- 238000007605 air drying Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005325 percolation Methods 0.000 claims description 5
- 229940069949 propolis Drugs 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000013019 agitation Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 16
- 208000002193 Pain Diseases 0.000 abstract description 14
- 210000003205 muscle Anatomy 0.000 abstract description 13
- 230000008961 swelling Effects 0.000 abstract description 8
- 210000000988 bone and bone Anatomy 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 4
- 241000195954 Lycopodium clavatum Species 0.000 abstract description 3
- 240000001659 Oldenlandia diffusa Species 0.000 abstract description 3
- 235000021419 vinegar Nutrition 0.000 abstract description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 241000258920 Chilopoda Species 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 2
- 230000036783 anaphylactic response Effects 0.000 abstract description 2
- 208000003455 anaphylaxis Diseases 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000052 vinegar Substances 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- 241000131329 Carabidae Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 229940065115 grapefruit extract Drugs 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000006870 function Effects 0.000 description 17
- 241000256836 Apis Species 0.000 description 15
- 229930182470 glycoside Natural products 0.000 description 11
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 235000013616 tea Nutrition 0.000 description 9
- 241000256844 Apis mellifera Species 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- -1 phenol glycoside Chemical class 0.000 description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- IBIPGYWNOBGEMH-DILZHRMZSA-N asperuloside Chemical compound O([C@@H]1OC=C2C(=O)O[C@H]3C=C([C@@H]1[C@H]32)COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBIPGYWNOBGEMH-DILZHRMZSA-N 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- WSGPLSDARZNMCW-FCVLBCLDSA-N 6beta-Hydroxygeniposide Natural products O([C@@H]1OC=C([C@@H]2[C@H]1C(=C[C@@H]2O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WSGPLSDARZNMCW-FCVLBCLDSA-N 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WSGPLSDARZNMCW-UHFFFAOYSA-N Deacetylasperulosidsaeure-methylester Natural products OC1C=C(CO)C2C1C(C(=O)OC)=COC2OC1OC(CO)C(O)C(O)C1O WSGPLSDARZNMCW-UHFFFAOYSA-N 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- BZPMXJKRKXDRID-UOIKKKDVSA-N Scandoside Natural products OC[C@H]1O[C@@H](O[C@H]2CC=C([C@@H]3[C@@H](O)C=C(CO)[C@H]23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O BZPMXJKRKXDRID-UOIKKKDVSA-N 0.000 description 3
- WSGPLSDARZNMCW-LPGRTNKPSA-N Scandoside methyl ester Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=C[C@H]2O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WSGPLSDARZNMCW-LPGRTNKPSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 3
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 3
- 208000013219 diaphoresis Diseases 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 3
- 229940052490 naringin Drugs 0.000 description 3
- 229930019673 naringin Natural products 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZVXWFPTVHBWJOU-AWQYILTISA-N (1s,4as,5r,7as)-5-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C(C(O)=O)=CO1 ZVXWFPTVHBWJOU-AWQYILTISA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- CQGDBBBZCJYDRY-UHFFFAOYSA-N 1-methoxyanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2OC CQGDBBBZCJYDRY-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 101100383903 Mus musculus Cisd3 gene Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- LRZFEBJUJIQVDQ-UHFFFAOYSA-N methyl 2-(dimethylamino)acetate Chemical compound COC(=O)CN(C)C LRZFEBJUJIQVDQ-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000009991 scouring Methods 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- JNNGEAWILNVFFD-OZFVSFPVSA-N (1s,4as,6s,7s,7as)-6-hydroxy-7-methyl-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)C[C@H](O)[C@H]2C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JNNGEAWILNVFFD-OZFVSFPVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- MMOPREBWKCZVPO-FFSXNKAYSA-N (e)-3-(4-hydroxyphenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1.OC(=O)\C=C\C1=CC=C(O)C=C1 MMOPREBWKCZVPO-FFSXNKAYSA-N 0.000 description 1
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- WCRMDMYSQWZTSF-UHFFFAOYSA-N 2-hydroxy-1-methoxy-3-methylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(C)C(O)=C2OC WCRMDMYSQWZTSF-UHFFFAOYSA-N 0.000 description 1
- RNJHIYAJJKOFIO-UHFFFAOYSA-N 2-hydroxy-3-methylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(C)C(O)=C2 RNJHIYAJJKOFIO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- JNNGEAWILNVFFD-BFWCLYIISA-N 8-Epiloganic acid Natural products O=C(O)C=1[C@@H]2[C@H]([C@H](C)[C@@H](O)C2)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)OC=1 JNNGEAWILNVFFD-BFWCLYIISA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- DGDWCRWJRNMRKX-DILZHRMZSA-N Asperulosidic acid Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)[C@@H](O)C=C2COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGDWCRWJRNMRKX-DILZHRMZSA-N 0.000 description 1
- DGDWCRWJRNMRKX-UHFFFAOYSA-N Asperulosidinsaeure Natural products CC(=O)OCC1=CC(O)C(C(=CO2)C(O)=O)C1C2OC1OC(CO)C(O)C(O)C1O DGDWCRWJRNMRKX-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 235000000882 Citrus x paradisi Nutrition 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001427554 Corydiidae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- VKWWRUZYBNTDHM-AXECJBQYSA-N Deacetylasperulosidic acid Natural products OCC1=C[C@H](O)[C@H]2[C@@H]1[C@H](OC[C@H]3O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]3O)OC=C2C(=O)O VKWWRUZYBNTDHM-AXECJBQYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 241001312741 Gekko swinhonis Species 0.000 description 1
- ZJDOESGVOWAULF-OGJQONSISA-N Geniposidic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=CC[C@@H]2C(C(O)=O)=CO1 ZJDOESGVOWAULF-OGJQONSISA-N 0.000 description 1
- VYAALAFRWREWLA-BVTMAQQCSA-N Geniposidic acid Natural products CCC1=CC[C@H]2[C@@H]1[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C2C(=O)O VYAALAFRWREWLA-BVTMAQQCSA-N 0.000 description 1
- ZJDOESGVOWAULF-UHFFFAOYSA-N Geniposidinsaeure Natural products OC1C(O)C(O)C(CO)OC1OC1C2C(CO)=CCC2C(C(O)=O)=CO1 ZJDOESGVOWAULF-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 241000218300 Liriodendron Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001264480 Lycopodiastrum casuarinoides Species 0.000 description 1
- 241000927897 Lycopodium japonicum Species 0.000 description 1
- 244000079672 Magnolia coco Species 0.000 description 1
- 235000006072 Magnolia coco Nutrition 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001481692 Mesobuthus martensii Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241001334235 Scolopendra mutilans Species 0.000 description 1
- 241000131792 Scolopendridae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229930185474 acteoside Natural products 0.000 description 1
- FBSKJMQYURKNSU-ZLSOWSIRSA-N acteoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FBSKJMQYURKNSU-ZLSOWSIRSA-N 0.000 description 1
- FBSKJMQYURKNSU-UKQWSTALSA-N acteoside I Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)C=Cc4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O FBSKJMQYURKNSU-UKQWSTALSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- COUXBBBIXWWAEP-AGUBZPQCSA-N asperuloside Natural products CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](OC[C@H]4O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]4O)[C@H]1[C@H]23 COUXBBBIXWWAEP-AGUBZPQCSA-N 0.000 description 1
- AHFAQKUDQUDLNP-AGUBZPQCSA-N asperulosidic acid Natural products CC(=O)OCC1=C[C@H](O)[C@H]2[C@@H]1[C@H](OC[C@H]3O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]3O)OC=C2C(=O)O AHFAQKUDQUDLNP-AGUBZPQCSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- PJWPOUFMMWFJOL-UHFFFAOYSA-N beta-sitosterol-beta-D-glucoside Natural products CCC(CCC(C)C1CCC2C3C=CC4CC(CCC4(C)C3CCC12C)OC5OC(CO)C(O)C(O)C5O)C(C)C PJWPOUFMMWFJOL-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- OVYQSRKFHNKIBM-UHFFFAOYSA-N butanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)CCC(O)=O OVYQSRKFHNKIBM-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- YDDMELPLARDERH-UHFFFAOYSA-N cistanoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(OC(=O)C)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5ccc(O)c(O)c5)C(O)C(O)C1O YDDMELPLARDERH-UHFFFAOYSA-N 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 description 1
- NJYVDFDTLLZVMG-UHFFFAOYSA-N echinacoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5cc(O)cc(O)c5)C(O)C(O)C1O NJYVDFDTLLZVMG-UHFFFAOYSA-N 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- JNNGEAWILNVFFD-UHFFFAOYSA-N epiloganic acid Natural products CC1C(O)CC(C(=CO2)C(O)=O)C1C2OC1OC(CO)C(O)C(O)C1O JNNGEAWILNVFFD-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/40—Products in which the composition is not well defined
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/40—Products in which the composition is not well defined
- C11D7/44—Vegetable products
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/40—Products in which the composition is not well defined
- C11D7/46—Animal products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- C11D2111/12—
Abstract
本发明公开了一种应用于风湿性关节炎的中药香皂,它是由下述重量份的原料配制成的:当归10~30份、土元20~40份、伸筋草10~25份、杜仲10~25份、三七10~25份、全虫20~40份、肉苁蓉提取物20~40份、桂枝10~25份、蜈蚣8~15份、白花蛇草20~40份、蜂产品三宝素10~25份、柚子提取物10~25份、醋蛋液10~15份、绿茶提取物5~10份、山茶油提取物5~10份。本发明的中药香皂生产工艺简易、干净卫生、使用无过敏反应,能够祛风胜湿、消肿止痛、恢复筋骨、发汗解肌、疏散风热、温经通阳、行气活血疏经通络的经科学配伍制得中药香皂使用方便,无副作用标本兼治功能疗效确切,效果显著。
Description
技术领域
本发明涉及中药香皂,通过中药成分组合成香皂通过洗涤部位缓解治疗风湿性关节炎疾病,具体为提供一种应用于风湿性关节炎的中药香皂。
背景技术
风湿性关节炎是一种常见的急性或慢性结缔组织炎症。风湿性关节炎广义上应该包括类风湿性关节炎。可反复发作并累及心脏。临床以关节和肌肉游走性酸楚、重著、疼痛为特征。属变态反应性疾病。是风湿热的主要表现之一,多以急性发热及关节疼痛起病。
香皂是现在家居生活不可缺少的一种保洁产品,大多数人选择使用香皂看中的是其的去油、除菌功能比较显著,中药香皂针对性研发风湿性领域还未能涉及到,中药香皂除了洗涤,还是直接涂抹,达到双重效果,是每个患者迫切喜爱的。
发明内容
本发明的目的在于提供中药香皂洗涤为主、外用涂抹为辅助,双管齐下能够祛风胜湿、消肿止痛、恢复筋骨、发汗解肌、疏散风热、温经通阳、行气活血疏经通的一种应用于风湿性关节炎的中药香皂,来解决上述背景技术所提出的问题。
为了实现上述目的,因此本发明提供如下技术方案:
本发明的一种应用于风湿性关节炎的中药香皂,它是由下述重量份的原料配制成的:当归10~30份、土元20~40份、伸筋草10~25份、杜仲10~25份、三七10~25份、全虫20~40份、肉苁蓉提取物20~40份、桂枝10~25份、蜈蚣8~15份、白花蛇草20~40份、蜂产品三宝素10~25份、柚子提取物10~25份、醋蛋液10~15份、绿茶提取物5~10份、山茶油提取物5~10份。
优选的,所述的中药香皂是由下述重量份的原料配制成的:当归20份、土元30份、伸筋草15份、杜仲15份、三七15份、全虫30份、肉苁蓉提取物30份、桂枝15份、蜈蚣10份、白花蛇草30份、蜂产品三宝素20份、柚子提取物15份、醋蛋液15份、绿茶提取物8份、山茶油提取物6份。
优选的,所述蜂产品三宝素指的是蜂蜜与蜂王浆、蜂花粉或蜂胶液任意2种调配。
本发明所采用的药材具有如下特性:
当归:【来源】本品为伞形科植物当归Angelica sinensis (Oliv.) Diels 的干燥根。【性味】甘、辛,温。【归经】归肝、心、脾经。【功能主治】补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
土元:别名土鳖虫,中药名。为鳖蠊科昆虫地鳖Eupolyph,aga sin,ensis Walker或冀地鳖Steleophaga Plancyi (Boleny)的雌虫干燥体。【性味】咸,寒;有小毒。【归经】归肝经。【功能主治】破瘀血,续筋骨。用于筋骨折伤,瘀血经闭,症瘕痞块。
伸筋草:【别名】石松、狮子尾、狮子草、绿毛伸筋、小伸筋、舒筋草【来源】本品为石松科植物石松Lycopodium japonicum Thunb. 的干燥全草。【性味】微苦、辛,温。
【归经】归肝、脾、肾经。【功能主治】祛风除湿,舒筋活络。用于关节酸痛,屈伸不利。
杜仲:【别名】扯丝皮、思仲、丝棉皮、玉丝皮,【来源】本品为杜仲科植物杜仲Eucommia ulmoides Oliv. 的干燥树皮。【性味】甘,温。【归经】归肝、肾经。【功能主治】补肝肾,强筋骨,安胎。用于肾虚腰痛,筋骨无力,妊娠漏血,胎动不安;高血压。
三七:【来源】本品为五加科植物三七Panax notoginseng (Burk.)F. H. Chen的干燥根。【性味】甘、微苦,温。【归经】归肝、胃经。【功能主治】散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹剌痛,跌扑肿痛。
全虫:别名全蝎,中药名。为钳蝎科动物东亚钳蝎Buthus martensii Karsch的干燥体。【性味】辛,平;有毒。【归经】归肝经。【功能主治】息风镇痉,攻毒散结,通络止痛。用于小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。
肉苁蓉提取物:肉苁蓉提取物是从寄生植物肉苁蓉中提取的物质,可用于增强性能力。肉质茎含肉苁蓉甙(cistanoside)A、B、C、H,洋丁香酚甙(acteoside),2-乙酰基洋丁香酚甙(2-acetylacteoside),海胆甙(echinacoside)七种苯乙醇甙成分,还含鹅掌楸甙(lirio-dendrin),8-表马钱子甙酸(8-epiloganic acid),胡萝卜甙(daucos-terol),甜菜碱(betaine),β-谷甾醇(β-sitosterol),甘露醇(mannitol),N,N-二甲基甘按酸甲酯(N,N-dimethylglycinemethyl ester)和苯丙氨酸(phenylalanine),缬氨酸(valine),亮氨酸(leucine),异亮氨酸(isoleacine),赖氨酸(lysine),苏氨酸(serine)等十五种氨基酸及琥珀酸(succinic acid),三十烷醇(TCMLIBiacontanol),多糖类。性味味甘;咸;性温,归经,归肾;大肠经,功能主治补肾阳;益精血;润肠道。主肾阳虚衰;精血不足之阳痿;遗精;白浊;尿频余沥;腰痛脚弱;耳鸣目花;月经衍期;宫寒不孕;肠燥便秘。
桂枝:【来源】本品为樟科植物肉桂 Cinnamomum cassia Presl的干燥嫩枝。【性味】辛、甘,温。【归经】归心、肺、膀胱经。【功能主治】发汗解肌,温通经脉,助阳化气,平冲降气。用于风寒感冒,脘腹冷痛,血寒经闭,关节痹痛,痰饮,水肿,心悸,奔豚。
蜈蚣:【别名】百足虫、千足虫、金头蜈蚣、百脚,【来源】本品为蜈蚣科动物少棘巨蜈蚣Scolopendra subspinipes mutilans L. Koch的干燥体。【性味】辛,温;有毒。【归经】归肝经。【功能主治】息风镇痉,功毒散结,通络止痛。用于小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,疮疡,瘰疬,毒蛇咬伤。
白花蛇草:白花蛇草,即白花蛇舌草,一年生无毛纤细披散草本植物,可入药;茎稍扁,从基部开始分枝。药材基源:为双子叶植物药茜草科植物白花蛇舌草的带根全草。拉丁植物动物矿物名:Hedyotis diffusa Willd. [Olden-landia diffusa (Willd.) Roxb.]【化学成份】全草含车叶草甙(asperuloside),车叶草甙酸(asperulosidic acid),去乙酸基车叶草甙酸(deacetylasperulosidicacid),都桷子甙酸(genipoSidic acid),鸡屎藤次甙(scandoside),鸡屎藤次甙甲酯(scandodide methyl ester), 6-O-对-羟基桂皮酰鸡屎藤次甙甲酯(6-O-p-hydroxycinnamoyl scandoside methylester),6-O-对-甲氧基桂皮酰鸡屎藤次甙甲酯(6-O-P-methO-xycinnamlyl scandoside methyl ester),6-O-阿魏酰鸡屎藤次甙甲酯(6-O-feruloyl scandoside methyl ester),2-甲基-3-羟基蒽醌(2-methyL-3-hvdroxyanthraquinone),2-甲基-3-甲氧基蒽醌(2-methyl-3-methoxyanthraquinone),2-甲基-3-羟基-4-甲氧基蒽醌(2-methyl-3-hvdroxy-4-methoxyanthraquinone)等[1-3],以及熊果酸(ursolic acid),β-谷甾醇(β-sitosterol)[4],三十一烷(hentriacon-tane),豆甾醇(stigmasterol),齐墩果酸(oleanolic acid),β-谷甾醇-β-葡萄糖甙(β-sitosterol-β-D-glucoside),对-香豆酸(p-coumaricacid)【性味】苦甘;寒;无毒【归经】心;肝;脾;大肠经【功能主治】清热解毒;利湿。主肺热喘咳;咽喉肿痛;肠痈;疖肿疮疡;毒蛇咬伤;热淋涩痛;水肿;痢疾;肠炎;湿热黄疸;癌肿。
蜂产品三宝素:蜂三宝是〔蜂王浆+蜂蜜+蜂花粉〕调配而成的养生圣品,它一次拥有蜂王浆、蜂蜜、蜂花粉的营养,同时也把蜂王浆变好吃了,是让想吃又害怕蜂王乳味道的人,最佳的选择!同时相比较蜂王浆更易保存。
蜂王浆:镇静安眠、调节血压、护肝防癌、健脑益智、延年益寿、美容护肤、滋补神经、加强造血功能。并广泛应用于以下疾病:老年综合症、营养不良、食欲不振、糖尿病、血管及血液系统疾病、神经系统疾病、调节肝脏功能、抑制肿瘤、风湿性关节炎、前列腺炎。
蜂蜜含有与人体血清浓度相近的多种无机盐和维生素、铁、钙、铜、锰、钾、磷等多种有机酸和有益人体健康的微量元素,以及果糖、葡萄糖、淀粉酶、氧化酶、还原酶等,具有滋养、润燥、解毒之功效。能改善血液的成分,促进心脑和血管功能,因此经常服用于心血管病人很有好处,蜂蜜能迅速补充体力,消除疲劳,增强对疾病的抵抗力
蜂花粉:氨基酸含量高,微量元素及血酸含量高。可防止动脉硬化和肿瘤,对失眠、肠胃等疾病的治疗效果良好,是大自然赋予人类的“全能营养库”,又是“浓缩的天然维生素胶丸”,具有独特的医疗保健功能。美容护肤也首选花粉, 被誉为“可以服用的化妆品”。
柚子提取物:【别 名】 柚甙、柚皮甙等,【来 源】 为芸香科植物柚,葡萄柚的未成熟或近成熟的干燥外层果皮。【物理性质】 为淡黄色结晶粉末。溶于丙酮、乙醇、热醋酸和热水,不溶于乙醚、己烷和氯仿。【功能与主治】柚皮苷具有抗炎镇痛、抗病毒、抑菌及抑制眼醛糖还原酶的作用。
醋蛋液:醋蛋液顾名思义就是将洗净的蛋壳浸泡在纯天然酿造最低2年米醋中2—4天,泡好后可与白开水、蜂蜜一起调匀食用。醋蛋可调整与弥补人体营养状况,改善和提高新陈代谢水平,增强体质,提高抗病、免疫等防治疾病的功能.对高血压、脑血栓后遗症、气管炎、风湿痛、失眠、便秘、胃下垂、肩周炎和糖尿病等效果较显著,而对结肠炎、心脑供血不全、神经痛、神经衰弱、动脉硬化、盗汗、腹泻、肾炎、皮炎、骨质增生和口臭等多种疾患有疗效。
绿茶提取物:从绿茶叶片中提取的活性成分,主要包括茶多酚(儿茶素)等。具有抗氧化、清除自由基等作用。茶多酚(GTP)、咖啡碱、芳香油、水分、矿物质、色素、碳水化合物、蛋白质、氨基酸、维生素等。茶多酚能杀灭肉毒杆菌及孢子,抑制细菌外毒素的活性。对引起腹泻、呼吸道和皮肤感染的各种病原菌有抗菌作用。茶多酚对引起化脓性感染、烧伤、外伤的金黄色葡萄球菌、变型杆菌有明显的抑制作用。【抗氧化作用】:茶多酚可阻断脂质过氧化过程,提高人体内酶的活性,从而起到抗突变、抗癌症的功效。【清毒作用】:严重的环境污染对人体健康具有明显的毒害作用,茶多酚对重金属具有强的吸附作用,能与重金属形成络合物而产生沉淀,有利于减轻重金属对人体产生的毒害作用。另外,茶多酚还具有改善肝功能和利尿的作用,因而对生物碱中毒有较好的抗解作用。【提高机体免疫力】:茶多酚通过提高人体免疫球蛋白总量并使其维持在高水平,刺激抗体活性的变化,从而提高人的总体免疫能力,并可促进人体的自身调理功能。
山茶油提取物:山茶油含有维生素E和抗氧化成分,因此它能保护皮肤,尤其能防止皮肤损伤和衰老,使皮肤具有光泽。山茶油是最典型的单一不饱和油脂。它是一种保持山茶口味、香气、维生素和性质的天然汁液。是唯一从木本植物果中榨取后能直接食用的植物油。山茶油主要成分为油酸,其含量高达 75%左右,此外还含有丰富的维生素E、胡萝卜素和其它抗氧化剂。
本发明还提供上述一种应用于风湿性关节炎的中药香皂的制备方法,本技术领域中通常人们采用熟知的方法包括如下步骤:
1)称取下述各原料:当归20份、土元30份、伸筋草15份、杜仲15份、三七15份、全虫30份、肉苁蓉提取物30份、桂枝15份、蜈蚣10份、白花蛇草30份、蜂产品三宝素20份、柚子提取物15份、醋蛋液15份、绿茶提取物8份、山茶油提取物6份;
2)取当归、土元、伸筋草、杜仲、三七、全虫、桂枝、蜈蚣、白花蛇草中药各材料,将上述中药原料粉碎成粗粉,用其总量的10倍量的60%乙醇先浸泡30分钟后进行渗漉,收集渗漉液,回收乙醇至渗漉液无醇味,并浓缩至60℃时测相对密度为1.10~1.15的稠膏;
3)将肉苁蓉提取物、蜂产品三宝素、柚子提取物、醋蛋液、绿茶提取物、山茶油提取物原料倒入步骤2)所得稠膏中不断搅拌至胶块完全烊化,再经60目药筛滤过,倒入砂锅继续加热搅拌成膏滋;
4)将上述步骤3)所得膏滋加入食用乙醇、天然皂角一同混合过滤压榨成液态膏后静置风干,待静置风干完毕后进行抽空处理即得成品。
用法及用量:
使用本发明的中药香皂时,先用温水擦洗相关关节部位,之后涂抹中药香皂,充分润湿起水泡泡,充分吸收10分钟左右,清水冲干即可。另建议擦洗冲干净后再往关节疼痛部位涂上一层本发明的中药香皂让其自由吸收效果更佳,夏日可一天使用二次,冬日三天一次。
有益效果
本发明的一种应用于风湿性关节炎的中药香皂的优点在于:
(1)提供了能能够祛风胜湿、消肿止痛、恢复筋骨、发汗解肌、疏散风热、温经通阳、行气活血疏经通络的经科学配伍制得中药香皂使用方便,无副作用标本兼治功能疗效确切,效果显著,增加了风湿性关节炎外用药物新领域。
(2)本发明的应用于风湿性关节炎的中药香皂对常见的急性或慢性结缔组织炎症等,具有快速调理作用,临床验证表明本发明的应用于风湿性关节炎的中药香皂效果显著,本发明的应用于风湿性关节炎的中药香皂,所达疗效是本领域普通技术人员意想不到的。
(3)本发明的应用于风湿性关节炎的中药香皂,制备工艺简单、本发明的中药香皂生产工艺简易、干净卫生、使用无过敏反应,易吸收、无刺激、服用安全、携带方便等特点,具有广大经济效益和社会效益。
具体实施方式
实施例1
原料:当归20份、土元30份、伸筋草15份、杜仲15份、三七15份、全虫30份、肉苁蓉提取物30份、桂枝15份、蜈蚣10份、白花蛇草30份、蜂蜜11份、蜂王浆3份、蜂花粉6份、柚子提取物15份、醋蛋液15份、绿茶提取物8份、山茶油提取物6份。
制备:
1)称取下述各原料:当归20份、土元30份、伸筋草15份、杜仲15份、三七15份、全虫30份、肉苁蓉提取物30份、桂枝15份、蜈蚣10份、白花蛇草30份、蜂蜜11份、蜂王浆3份、蜂花粉6份、柚子提取物15份、醋蛋液15份、绿茶提取物8份、山茶油提取物6份;
2)取当归、土元、伸筋草、杜仲、三七、全虫、桂枝、蜈蚣、白花蛇草中药各材料,将上述中药原料粉碎成粗粉,用其总量的10倍量的60%乙醇先浸泡30分钟后进行渗漉,收集渗漉液,回收乙醇至渗漉液无醇味,并浓缩至60℃时测相对密度为1.10~1.15的稠膏;
3)将肉苁蓉提取物、蜂蜜、蜂王浆、蜂花粉、柚子提取物、醋蛋液、绿茶提取物、山茶油提取物原料倒入步骤2)所得稠膏中不断搅拌至胶块完全烊化,再经60目药筛滤过,倒入砂锅继续加热搅拌成膏滋;
4)将上述步骤3)所得膏滋加入食用乙醇、天然皂角一同混合过滤压榨成液态膏后静置风干,待静置风干完毕后进行抽空处理即得成品。
用法及用量:
使用本发明的中药香皂时,先用温水擦洗相关关节部位,之后涂抹中药香皂,充分润湿起水泡泡,充分吸收10分钟左右,清水冲干即可。另建议擦洗冲干净后再往关节疼痛部位涂上一层本发明的中药香皂让其自由吸收效果更佳,夏日可一天使用二次,冬日三天一次。
实施例2
原料:当归30份、土元40份、伸筋草25份、杜仲25份、三七25份、全虫40份、肉苁蓉提取物40份、桂枝25份、蜈蚣15份、白花蛇草40份、蜂蜜13份、蜂王浆4份、蜂胶液8份、柚子提取物25份、醋蛋液15份、绿茶提取物10份、山茶油提取物10份。
制备:
1)称取下述各原料:当归30份、土元40份、伸筋草25份、杜仲25份、三七25份、全虫40份、肉苁蓉提取物40份、桂枝25份、蜈蚣15份、白花蛇草40份、蜂蜜13份、蜂王浆4份、蜂胶液8份、柚子提取物25份、醋蛋液15份、绿茶提取物10份、山茶油提取物10份;
2)取当归、土元、伸筋草、杜仲、三七、全虫、桂枝、蜈蚣、白花蛇草中药各材料,将上述中药原料粉碎成粗粉,用其总量的10倍量的60%乙醇先浸泡30分钟后进行渗漉,收集渗漉液,回收乙醇至渗漉液无醇味,并浓缩至60℃时测相对密度为1.10~1.15的稠膏;
3)将肉苁蓉提取物、蜂蜜、蜂王浆、蜂胶液、柚子提取物、醋蛋液、绿茶提取物、山茶油提取物原料倒入步骤2)所得稠膏中不断搅拌至胶块完全烊化,再经60目药筛滤过,倒入砂锅继续加热搅拌成膏滋;
4)将上述步骤3)所得膏滋加入食用乙醇、天然皂角一同混合过滤压榨成液态膏后静置风干,待静置风干完毕后进行抽空处理即得成品。
用法与用量同实施例1相同。
实施例3
原料:当归10份、土元20份、伸筋草10份、杜仲12份、三七15份、全虫30份、肉苁蓉提取物25份、桂枝15份、蜈蚣10份、白花蛇草25份、蜂蜜9份、蜂王浆2份、蜂花粉4份、柚子提取物12份、醋蛋液12份、绿茶提取物6份、山茶油提取物8份。
制备:
1)称取下述各原料:当归10份、土元20份、伸筋草10份、杜仲12份、三七15份、全虫30份、肉苁蓉提取物25份、桂枝15份、蜈蚣10份、白花蛇草25份、蜂蜜9份、蜂王浆2份、蜂花粉4份、柚子提取物12份、醋蛋液12份、绿茶提取物6份、山茶油提取物8份;
2)取当归、土元、伸筋草、杜仲、三七、全虫、桂枝、蜈蚣、白花蛇草中药各材料,将上述中药原料粉碎成粗粉,用其总量的10倍量的60%乙醇先浸泡30分钟后进行渗漉,收集渗漉液,回收乙醇至渗漉液无醇味,并浓缩至60℃时测相对密度为1.10~1.15的稠膏;
3)将肉苁蓉提取物、蜂蜜、蜂王浆、蜂花粉、柚子提取物、醋蛋液、绿茶提取物、山茶油提取物原料倒入步骤2)所得稠膏中不断搅拌至胶块完全烊化,再经60目药筛滤过,倒入砂锅继续加热搅拌成膏滋;
4)将上述步骤3)所得膏滋加入食用乙醇、天然皂角一同混合过滤压榨成液态膏后静置风干,待静置风干完毕后进行抽空处理即得成品。
用法与用量同实施例1相同。
病例1 张女士,浙江温州人,50岁,患者描述:小时候家里很穷,衣服一直穿的不多,久而久之,手腕部和小腿关节就开始肿胀疼痛,小时候不怎么在意,现在年纪大了,发觉越发疼痛了,衣服穿的再多也不管用。去了医院才发现是得了类风湿性关节炎。使用本发明的中药香皂后,手腕部肿胀退去了,疼痛不明显了,30天后完全治愈。
病例2 罗先生,重庆人,48岁,患者描述:15年上半年梅雨季节连续下了好几天雨,之后出现两腿、左胳膊关节疼痛,在当地卫生诊所治疗,医生告知是风湿性关节炎,经配药后疗效欠佳。后来经配药介绍有本发明的关节炎相关的中药香皂治疗效果显著,抱着试试看的心,因其不打针不吃药,无毒无副作用,每天擦洗1-2次很方便,通过治疗周期15天后,发现腿部、胳膊疼痛减少了,胀气开始消退了,继续使用20天完全治愈,之后患者把中药香皂当做平常沐浴产品使用,至今未见复发。
Claims (4)
1.一种应用于风湿性关节炎的中药香皂,其特征在于,它是由下述重量份的原料配制成的:当归10~30份、土元20~40份、伸筋草10~25份、杜仲10~25份、三七10~25份、全虫20~40份、肉苁蓉提取物20~40份、桂枝10~25份、蜈蚣8~15份、白花蛇草20~40份、蜂产品三宝素10~25份、柚子提取物10~25份、醋蛋液10~15份、绿茶提取物5~10份、山茶油提取物5~10份。
2.根据权利要求1所述的一种应用于风湿性关节炎的中药香皂,其特征在于,它是由下述重量份的原料配制成的:当归20份、土元30份、伸筋草15份、杜仲15份、三七15份、全虫30份、肉苁蓉提取物30份、桂枝15份、蜈蚣10份、白花蛇草30份、蜂产品三宝素20份、柚子提取物15份、醋蛋液15份、绿茶提取物8份、山茶油提取物6份。
3.根据权利要求1所述的一种应用于风湿性关节炎的中药香皂的制备方法,其特征在于该方法包括如下步骤:
1)称取下述各原料:当归20份、土元30份、伸筋草15份、杜仲15份、三七15份、全虫30份、肉苁蓉提取物30份、桂枝15份、蜈蚣10份、白花蛇草30份、蜂产品三宝素20份、柚子提取物15份、醋蛋液15份、绿茶提取物8份、山茶油提取物6份;
2)取当归、土元、伸筋草、杜仲、三七、全虫、桂枝、蜈蚣、白花蛇草中药各材料,将上述中药原料粉碎成粗粉,用其总量的10倍量的60%乙醇先浸泡30分钟后进行渗漉,收集渗漉液,回收乙醇至渗漉液无醇味,并浓缩至60℃时测相对密度为1.10~1.15的稠膏;
3)将肉苁蓉提取物、蜂产品三宝素、柚子提取物、醋蛋液、绿茶提取物、山茶油提取物原料倒入步骤2)所得稠膏中不断搅拌至胶块完全烊化,再经60目药筛滤过,倒入砂锅继续加热搅拌成膏滋;
4)将上述步骤3)所得膏滋加入食用乙醇、天然皂角一同混合过滤压榨成液态膏后静置风干,待静置风干完毕后进行抽空处理即得成品。
4.根据权利要求1所述的一种应用于风湿性关节炎中药香皂,其特征在于,所述蜂产品三宝素指的是蜂蜜与蜂王浆、蜂花粉或蜂胶液任意2种调配。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610434434.1A CN105902690A (zh) | 2016-06-19 | 2016-06-19 | 一种应用于风湿性关节炎的中药香皂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610434434.1A CN105902690A (zh) | 2016-06-19 | 2016-06-19 | 一种应用于风湿性关节炎的中药香皂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105902690A true CN105902690A (zh) | 2016-08-31 |
Family
ID=56751619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610434434.1A Withdrawn CN105902690A (zh) | 2016-06-19 | 2016-06-19 | 一种应用于风湿性关节炎的中药香皂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105902690A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106833964A (zh) * | 2017-01-11 | 2017-06-13 | 陈礼刚 | 一种植物皂基按摩膏及其制备方法 |
CN114075485A (zh) * | 2020-08-10 | 2022-02-22 | 浙江禄益善健康管理咨询有限公司 | 一种醋蛋皂 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101455783A (zh) * | 2008-12-05 | 2009-06-17 | 包头市红卫日用化工有限公司 | 风湿止痛皂及其制备方法 |
CN104152305A (zh) * | 2014-07-11 | 2014-11-19 | 广东广海大实业有限公司 | 一种治疗风湿病的香皂及其制作方法 |
CN104450322A (zh) * | 2014-12-10 | 2015-03-25 | 青岛七好营养科技有限公司 | 一种中药香皂及其制备方法 |
CN104531396A (zh) * | 2014-12-10 | 2015-04-22 | 青岛七好营养科技有限公司 | 一种中药香皂及其制备方法 |
-
2016
- 2016-06-19 CN CN201610434434.1A patent/CN105902690A/zh not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101455783A (zh) * | 2008-12-05 | 2009-06-17 | 包头市红卫日用化工有限公司 | 风湿止痛皂及其制备方法 |
CN104152305A (zh) * | 2014-07-11 | 2014-11-19 | 广东广海大实业有限公司 | 一种治疗风湿病的香皂及其制作方法 |
CN104450322A (zh) * | 2014-12-10 | 2015-03-25 | 青岛七好营养科技有限公司 | 一种中药香皂及其制备方法 |
CN104531396A (zh) * | 2014-12-10 | 2015-04-22 | 青岛七好营养科技有限公司 | 一种中药香皂及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106833964A (zh) * | 2017-01-11 | 2017-06-13 | 陈礼刚 | 一种植物皂基按摩膏及其制备方法 |
CN114075485A (zh) * | 2020-08-10 | 2022-02-22 | 浙江禄益善健康管理咨询有限公司 | 一种醋蛋皂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656238B (zh) | 一种治疗风湿骨病的中药组合物 | |
CN102517191B (zh) | 一种男士滋补保健功能酒 | |
CN106074973A (zh) | 一种提高免疫力的组合物及其制备方法 | |
CN105288597A (zh) | 一种治疗皮肤色素沉着的药物 | |
CN102807943A (zh) | 一种补肾乌发养颜的保健药酒 | |
CN102908474B (zh) | 一种治疗神经官能症的药酒 | |
CN105902690A (zh) | 一种应用于风湿性关节炎的中药香皂 | |
CN111166859A (zh) | 一种足浴粉及其制备方法 | |
CN105748374A (zh) | 中药嫩肤养颜美容液 | |
CN103520690B (zh) | 一种舒筋通络降压浴足粉 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN102266427A (zh) | 一种用于美容养颜的鹿茸当归酒及其制备方法和应用 | |
CN105167097A (zh) | 一种黑糯米发酵饮料 | |
CN104645063A (zh) | 一种治疗乳腺增生的丸剂及制备方法 | |
CN110882318A (zh) | 一种中药足浴包及其制备方法 | |
CN104940722A (zh) | 生精调经补肾酒 | |
CN105055789A (zh) | 一种缓解软组织损伤疼痛的中药熏洗液及其制备方法 | |
CN104784414A (zh) | 缓解脑梗塞后遗症的补脑安神饮及制备方法 | |
CN105288385A (zh) | 蝉蜕中药酒 | |
CN105031562A (zh) | 活血润燥酒 | |
CN104474198A (zh) | 固本地黄中药酒及制备方法 | |
CN103468530A (zh) | 一种鹿茸美容养颜酒的配方及生产方法 | |
CN103751622A (zh) | 一种治疗冠心病的药物组合物 | |
CN109674873A (zh) | 一种治疗风湿、运动创伤舒筋通络的外用药酒及其制备方法 | |
CN102370848A (zh) | 治疗妇女因湿邪白带的中草药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160831 |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Jinguo Document name: Notification of Approving Refund |